Application 214985
- Type
- NDA
- Sponsor
- IDORSIA PHARMACEUTICALS LTD.
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | QUVIVIQ | DARIDOREXANT | TABLET; ORAL | 25MG | No | No |
| 002 | QUVIVIQ | DARIDOREXANT | TABLET; ORAL | 50MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N214985-001 | QUVIVIQ | DARIDOREXANT HYDROCHLORIDE | EQ 25MG BASE | TABLET / ORAL | RLD | 2022-04-07 | |
| N214985-002 | QUVIVIQ | DARIDOREXANT HYDROCHLORIDE | EQ 50MG BASE | TABLET / ORAL | RLD, RS | 2022-04-07 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N214985-001 | 9732075 | 2033-06-03 | U-620 | Drug substance, Drug product | 2022-05-03 |
| N214985-001 | 10023560 | 2034-12-02 | U-620 | 2022-05-03 | |
| N214985-001 | 9790208 | 2034-12-02 | Drug substance, Drug product | 2022-05-03 | |
| N214985-002 | 9732075 | 2033-06-03 | U-620 | Drug substance, Drug product | 2022-05-03 |
| N214985-002 | 10023560 | 2034-12-02 | U-620 | 2022-05-03 | |
| N214985-002 | 9790208 | 2034-12-02 | Drug substance, Drug product | 2022-05-03 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N214985-001 | NCE | 2027-04-07 |
| N214985-001 | M-200 | 2027-09-30 |
| N214985-001 | M-310 | 2027-09-30 |
| N214985-002 | NCE | 2027-04-07 |
| N214985-002 | M-200 | 2027-09-30 |
| N214985-002 | M-310 | 2027-09-30 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N214985-001 | QUVIVIQ | EQ 25MG BASE | TABLET / ORAL | RLD | 2022-04-07 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N214985-002 | QUVIVIQ | EQ 50MG BASE | TABLET / ORAL | RLD, RS | 2022-04-07 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N214985-001 | QUVIVIQ | EQ 25MG BASE | TABLET / ORAL | RLD | 2022-04-07 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N214985-002 | QUVIVIQ | EQ 50MG BASE | TABLET / ORAL | RLD, RS | 2022-04-07 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N214985-001 | QUVIVIQ | EQ 25MG BASE | TABLET / ORAL | RLD | 2022-04-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214985-002 | QUVIVIQ | EQ 50MG BASE | TABLET / ORAL | RLD, RS | 2022-04-07 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214985-001 | QUVIVIQ | EQ 25MG BASE | TABLET / ORAL | RLD | 2022-04-07 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214985-002 | QUVIVIQ | EQ 50MG BASE | TABLET / ORAL | RLD, RS | 2022-04-07 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214985-001 | QUVIVIQ | EQ 25MG BASE | TABLET / ORAL | RLD | 2022-04-07 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214985-002 | QUVIVIQ | EQ 50MG BASE | TABLET / ORAL | RLD, RS | 2022-04-07 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N214985-001 | QUVIVIQ | EQ 25MG BASE | TABLET / ORAL | RLD | 2022-04-07 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N214985-002 | QUVIVIQ | EQ 50MG BASE | TABLET / ORAL | RLD, RS | 2022-04-07 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214985-001 | QUVIVIQ | EQ 25MG BASE | TABLET / ORAL | RLD | 2022-04-07 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214985-002 | QUVIVIQ | EQ 50MG BASE | TABLET / ORAL | RLD, RS | 2022-04-07 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214985-001 | QUVIVIQ | EQ 25MG BASE | TABLET / ORAL | RLD | 2022-04-07 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214985-002 | QUVIVIQ | EQ 50MG BASE | TABLET / ORAL | RLD, RS | 2022-04-07 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214985-001 | QUVIVIQ | EQ 25MG BASE | TABLET / ORAL | RLD | 2022-04-07 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214985-002 | QUVIVIQ | EQ 50MG BASE | TABLET / ORAL | RLD, RS | 2022-04-07 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214985-001 | QUVIVIQ | EQ 25MG BASE | TABLET / ORAL | RLD | 2022-04-07 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214985-002 | QUVIVIQ | EQ 50MG BASE | TABLET / ORAL | RLD, RS | 2022-04-07 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214985-001 | QUVIVIQ | EQ 25MG BASE | TABLET / ORAL | RLD | 2022-04-07 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214985-002 | QUVIVIQ | EQ 50MG BASE | TABLET / ORAL | RLD, RS | 2022-04-07 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214985-001 | QUVIVIQ | EQ 25MG BASE | TABLET / ORAL | RLD | 2022-04-07 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214985-002 | QUVIVIQ | EQ 50MG BASE | TABLET / ORAL | RLD, RS | 2022-04-07 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N214985-001 | QUVIVIQ | EQ 25MG BASE | TABLET / ORAL | RLD | 2022-04-07 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N214985-002 | QUVIVIQ | EQ 50MG BASE | TABLET / ORAL | RLD, RS | 2022-04-07 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N214985-001 | QUVIVIQ | EQ 25MG BASE | TABLET / ORAL | RLD | 2022-04-07 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N214985-002 | QUVIVIQ | EQ 50MG BASE | TABLET / ORAL | RLD, RS | 2022-04-07 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N214985-001 | QUVIVIQ | EQ 25MG BASE | TABLET / ORAL | RLD | 2022-04-07 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N214985-002 | QUVIVIQ | EQ 50MG BASE | TABLET / ORAL | RLD, RS | 2022-04-07 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N214985-001 | QUVIVIQ | EQ 25MG BASE | TABLET / ORAL | RLD | 2022-04-07 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N214985-002 | QUVIVIQ | EQ 50MG BASE | TABLET / ORAL | RLD, RS | 2022-04-07 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N214985-001 | QUVIVIQ | EQ 25MG BASE | TABLET / ORAL | RLD | 2022-04-07 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N214985-002 | QUVIVIQ | EQ 50MG BASE | TABLET / ORAL | RLD, RS | 2022-04-07 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N214985-001 | QUVIVIQ | EQ 25MG BASE | TABLET / ORAL | RLD | 2022-04-07 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N214985-002 | QUVIVIQ | EQ 50MG BASE | TABLET / ORAL | RLD, RS | 2022-04-07 | 5c6f7cd8ea54… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N214985-001 | QUVIVIQ | EQ 25MG BASE | TABLET / ORAL | RLD | 2022-04-07 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N214985-002 | QUVIVIQ | EQ 50MG BASE | TABLET / ORAL | RLD, RS | 2022-04-07 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N214985-001 | QUVIVIQ | EQ 25MG BASE | TABLET / ORAL | RLD | 2022-04-07 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N214985-002 | QUVIVIQ | EQ 50MG BASE | TABLET / ORAL | RLD, RS | 2022-04-07 | 1c564ffb4f44… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214985-002 | 10023560 | 2034-12-02 | U-620 | 2022-05-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214985-002 | 9790208 | 2034-12-02 | Drug substance, Drug product | 2022-05-03 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214985-001 | 9732075 | 2033-06-12 | U-620 | Drug substance, Drug product | 2022-05-03 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214985-001 | 10023560 | 2034-12-02 | U-620 | 2022-05-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214985-001 | 9790208 | 2034-12-02 | Drug substance, Drug product | 2022-05-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214985-002 | 9732075 | 2033-06-12 | U-620 | Drug substance, Drug product | 2022-05-03 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214985-002 | 10023560 | 2034-12-02 | U-620 | 2022-05-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214985-002 | 9790208 | 2034-12-02 | Drug substance, Drug product | 2022-05-03 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214985-001 | 9732075 | 2033-06-12 | U-620 | Drug substance, Drug product | 2022-05-03 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214985-001 | 10023560 | 2034-12-02 | U-620 | 2022-05-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214985-001 | 9790208 | 2034-12-02 | Drug substance, Drug product | 2022-05-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214985-002 | 9732075 | 2033-06-12 | U-620 | Drug substance, Drug product | 2022-05-03 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214985-002 | 10023560 | 2034-12-02 | U-620 | 2022-05-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214985-002 | 9790208 | 2034-12-02 | Drug substance, Drug product | 2022-05-03 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214985-001 | 9732075 | 2033-06-12 | U-620 | Drug substance, Drug product | 2022-05-03 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214985-001 | 10023560 | 2034-12-02 | U-620 | 2022-05-03 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214985-001 | 9790208 | 2034-12-02 | Drug substance, Drug product | 2022-05-03 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214985-002 | 9732075 | 2033-06-12 | U-620 | Drug substance, Drug product | 2022-05-03 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214985-002 | 10023560 | 2034-12-02 | U-620 | 2022-05-03 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214985-002 | 9790208 | 2034-12-02 | Drug substance, Drug product | 2022-05-03 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214985-001 | 9732075 | 2033-06-12 | U-620 | Drug substance, Drug product | 2022-05-03 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214985-001 | 10023560 | 2034-12-02 | U-620 | 2022-05-03 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214985-001 | 9790208 | 2034-12-02 | Drug substance, Drug product | 2022-05-03 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214985-002 | 9732075 | 2033-06-12 | U-620 | Drug substance, Drug product | 2022-05-03 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214985-002 | 10023560 | 2034-12-02 | U-620 | 2022-05-03 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214985-002 | 9790208 | 2034-12-02 | Drug substance, Drug product | 2022-05-03 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214985-001 | 9732075 | 2033-06-12 | U-620 | Drug substance, Drug product | 2022-05-03 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214985-001 | 10023560 | 2034-12-02 | U-620 | 2022-05-03 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214985-001 | 9790208 | 2034-12-02 | Drug substance, Drug product | 2022-05-03 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214985-002 | 9732075 | 2033-06-12 | U-620 | Drug substance, Drug product | 2022-05-03 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214985-002 | 10023560 | 2034-12-02 | U-620 | 2022-05-03 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214985-002 | 9790208 | 2034-12-02 | Drug substance, Drug product | 2022-05-03 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N214985-001 | 9732075 | 2033-06-12 | U-620 | Drug substance, Drug product | 2022-05-03 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N214985-001 | 10023560 | 2034-12-02 | U-620 | 2022-05-03 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N214985-001 | 9790208 | 2034-12-02 | Drug substance, Drug product | 2022-05-03 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N214985-002 | 9732075 | 2033-06-12 | U-620 | Drug substance, Drug product | 2022-05-03 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N214985-002 | 10023560 | 2034-12-02 | U-620 | 2022-05-03 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N214985-002 | 9790208 | 2034-12-02 | Drug substance, Drug product | 2022-05-03 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N214985-001 | 9732075 | 2033-06-12 | U-620 | Drug substance, Drug product | 2022-05-03 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N214985-001 | 10023560 | 2034-12-02 | U-620 | 2022-05-03 | 79d66fd596c7… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N214985-001 | NCE | 2027-04-07 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N214985-001 | M-200 | 2027-09-30 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N214985-001 | M-310 | 2027-09-30 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N214985-002 | NCE | 2027-04-07 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N214985-002 | M-200 | 2027-09-30 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N214985-002 | M-310 | 2027-09-30 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N214985-001 | NCE | 2027-04-07 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N214985-001 | M-200 | 2027-09-30 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N214985-001 | M-310 | 2027-09-30 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N214985-002 | NCE | 2027-04-07 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N214985-002 | M-200 | 2027-09-30 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N214985-002 | M-310 | 2027-09-30 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N214985-001 | NCE | 2027-04-07 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N214985-001 | M-200 | 2027-09-30 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N214985-001 | M-310 | 2027-09-30 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N214985-002 | NCE | 2027-04-07 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N214985-002 | M-200 | 2027-09-30 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N214985-002 | M-310 | 2027-09-30 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N214985-001 | NCE | 2027-04-07 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214985-001 | M-200 | 2027-09-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214985-001 | M-310 | 2027-09-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214985-002 | NCE | 2027-04-07 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214985-002 | M-200 | 2027-09-30 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214985-002 | M-310 | 2027-09-30 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214985-001 | NCE | 2027-04-07 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214985-001 | M-200 | 2027-09-30 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214985-001 | M-310 | 2027-09-30 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214985-002 | NCE | 2027-04-07 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214985-002 | M-200 | 2027-09-30 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214985-002 | M-310 | 2027-09-30 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N214985-001 | NCE | 2027-04-07 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214985-001 | M-200 | 2027-09-30 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214985-001 | M-310 | 2027-09-30 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214985-002 | NCE | 2027-04-07 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214985-002 | M-200 | 2027-09-30 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214985-002 | M-310 | 2027-09-30 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214985-001 | NCE | 2027-04-07 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214985-001 | M-200 | 2027-09-30 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214985-001 | M-310 | 2027-09-30 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214985-002 | NCE | 2027-04-07 | fd3edfee7708… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| QUVIVIQ | DARIDOREXANT | Idorsia Pharmaceuticals Ltd | 3a2d1503-b816-40c9-9fac-7e03c5a3bcef | 2026-02-26 | Warnings, Adverse reactions | 214985 NDA214985 80491-7825 80491-7850 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 80491-7825 | QUVIVIQ | Daridorexant | Idorsia Pharmaceuticals Ltd | NDA | Current |
| 80491-7825 | QUVIVIQ | Daridorexant | Idorsia Pharmaceuticals Ltd | NDA | Current |
| 80491-7850 | QUVIVIQ | Daridorexant | Idorsia Pharmaceuticals Ltd | NDA | Current |
| 80491-7850 | QUVIVIQ | Daridorexant | Idorsia Pharmaceuticals Ltd | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 79797 | SUPPL | 2024-10-01 |
| 79796 | SUPPL | 2024-10-01 |
| 79795 | SUPPL | 2024-10-01 |
| 79792 | SUPPL | 2024-10-01 |
| 79791 | SUPPL | 2024-10-01 |
| 79790 | SUPPL | 2024-10-01 |
| 79788 | SUPPL | 2024-10-01 |
| 76741 | SUPPL | 2023-12-06 |
| 76010 | SUPPL | 2023-10-31 |
| 76009 | SUPPL | 2023-10-31 |
| 75994 | SUPPL | 2023-10-31 |
| 75993 | SUPPL | 2023-10-31 |
| 72589 | SUPPL | 2022-11-10 |
| 72588 | SUPPL | 2022-11-10 |
| 72583 | SUPPL | 2022-11-09 |
| 71542 | ORIG | 2022-07-13 |
| 70155 | ORIG | 2022-02-14 |
| 69833 | ORIG | 2022-01-11 |
| 69832 | ORIG | 2022-01-11 |
| 69829 | ORIG | 2022-01-11 |